Drug Discovery and Development
Uppsala University
Start date:
End date:
Pace of study: 100 %
Published education catalogue
Education information from the published source. The education record and its time-bound offerings are kept separate.
Code: 3FK229
The course deals with different phases in drug development; identification and validation of target molecule (the target), identification and optimisation of active substance, ADME-Tox profiling, in-vivo and in-vitro pharmacology, formulation, discovery and biomarkers and disease models, clinical trials, registration and commercialisation.
150 credits of which 90 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
Each offering has its own dates and conditions. Closed offerings are retained as history and do not mean that a new application is open.
Uppsala University
Start date:
End date:
Pace of study: 100 %
Retrieved: .
Published: .
Publication version: 8e217193-f5fa-4778-b085-a4521fd03e8d
Checksum: 1b0dc54c0fc8a359f83ba9dc8f9d468479ce432de4c03bce3b8b33dd67fe3f6c
Last changed according to the source: 2026-02-12T18:36:50